BTAI
BioXcel Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.07
−37.11%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.93x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.02x
- Price / sales
- 3.12x
- Price / cash flow
- -0.05x
Enterprise value
- Enterprise value
- $93.9M
- EV / sales
- 126.58x
- EV / EBITDA
- -1.76x
- EV / EBIT
- -2.10x
- Market cap
- $2.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026